News

Researchers claim COPD may be hereditary

23-Apr-08

COPD may be hereditary, claim researchers from Germany and Sweden.

It follows findings that siblings of COPD patients have a much greater risk of developing the disease than spouses.

Although smoking is known to be the most common cause of COPD, previous studies have suggested that there may be a genetic element. 

Data on over 14,000 patients who had been hospitalised for COPD in Sweden from 1986 to 2004 was analysed for the study. In this, 604 affected siblings were identified.

Standardised incidence ratios (SIRs) of COPD among siblings, twins and spouses were also calculated. 

Overall, the risk of COPD was found to be much higher in siblings (SIR of 11.87) than in spouses (SIR of 1.6).

sanjay.tanday@haymarket.com

Comment below and tell us what you think 


Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

Assessment guide is useful for all

Mock scenarios and helpful exercises make this book more than an exam guide, says Dr Lizzie Croton. Read more

Women's health - Terminate pregnancies

Requests for pregnancy termination should be handled with sensitivity, writes Dr Mona Kular. Read more

Clinical skills assessment

In the first of a regular look at the nMRCGP, Dr Daryl Goodwin explains how to pass the CSA. Read more

Show all articles

 

Latest Clinical Articles

Sjogren's syndrome

Contributed by Dr Jeffery Lee, consultant rheumatologist, Barnet Hospital, Hertfordshire. Read more

Chronic kidney disease

Section 1: Epidemiology and classification  Chronic kidney disease (CKD) encompasses abnor... Read more

Acute kidney injury

Contributed by Dr Stephan Brincat, specialist registrar, and Dr Rachel Hilton, consultant nephrologi... Read more

Show all clinical articles

MIMS Product News

New drug - Eucreas

Eucreas (vildagliptin + metformin) is a new fixed-dose combination treatment for patients inadequate... Read more

New drug - Galvus

Novartis has launched a new oral hypoglycaemic for the treatment type II diabetes. Read more

Coversyl formulation change

Coversyl and Coversyl Plus have been discontinued and replaced by Coversyl Arginine and Coversyl Arg... Read more

Jobs

 

Job of the Week